Hydrogen sulfide protects amyloid-β induced cell toxicity in microglia

Journal of Alzheimer's Disease

Volumn 22, Issue 4, 2010, Pages 1189-1200

  Liu, Yan Ying ^a   Bian, Jin Song ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Alzheimer's disease; amyloid; hydrogen sulfide; microglia; neuroprotection

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; CYCLOOXYGENASE 2; CYSTATHIONINE BETA SYNTHASE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HYDROGEN SULFIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; NITRIC OXIDE; S ADENOSYLMETHIONINE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE; CELL DAMAGE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HORMONE RELEASE; INFLAMMATION; MICROGLIA; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; UPREGULATION;

EID: 78650489401     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-101002     Document Type: Article

References (37)

1. Umemura K, Kimura H (2007) Hydrogen sulfide enhances reducing activity in neurons: neurotrophic role of H2S in the brain? Antioxid Redox Signal 9, 2035-2041. (Pubitemid 47622353)
2. Kimura H (2005) Hydrogen sulfide as a biological mediator. Antioxid Redox Signal 7, 778-780. (Pubitemid 40563218)
3. Zhang H, Zhi L,Moore PK, Bhatia M (2006) Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol 290, L1193-1201. (Pubitemid 43830864)
4. Abe K, Kimura H (1996) The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16, 1066-1071. (Pubitemid 26140863)
5. Ishigami M, Hiraki K, Umemura K, Ogasawara Y, Ishii K, Kimura H (2009) A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxid Redox Signal 11, 205-214.
6. Furne J, Saeed A, Levitt MD (2008) Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am J Physiol Regul Integr Comp Physiol 295, R1479-1485.
7. Nagai Y, Tsugane M, Oka J, Kimura H (2004) Hydrogen sulfide induces calcium waves in astrocytes. FASEB J 18, 557-559.
8. Lee SW,Hu YS,Hu LF,Lu Q,Dawe GS,Moore PK,Wong PT, Bian JS (2006) Hydrogen sulphide regulates calcium home-ostasis in microglial cells. Glia 54, 116-124. (Pubitemid 44078133)
9. Hu LF, Wong PT, Moore PK, Bian JS (2007) Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem 100, 1121-1128. (Pubitemid 46213934)
10. Lu M, Hu LF, Hu G, Bian JS (2008) Hydrogen sulfide protects astrocytes against H(2)O(2)-induced neural injury via enhancing glutamate uptake. Free Radic Biol Med 45, 1705-1713.
11. Hu LF, Lu M, Wu ZY, Wong PT, Bian JS (2009) Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function. Mol Pharmacol 75, 27-34.
12. Hu LF, Lu M, Tiong CX, Dawe GS, Hu G, Bian JS (2010) Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell 9, 135-146.
13. Braak H, Braak E (1997) Staging of Alzheimer-related cortical destruction. Int Psychogeriatr 9(Suppl 1), 257-261; discussion 269-272.
14. Berg L, McKeel DW, Jr., Miller JP, Baty J, Morris JC (1993) Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older. Arch Neurol 50, 349-358. (Pubitemid 23105458)
15. Eikelenboom P, Zhan SS, van Gool WA, Allsop D (1994) Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol Sci 15, 447-450. (Pubitemid 24379277)
16. Wojtera M, Sikorska B, Sobow T, Liberski PP (2005) Mi-croglial cells in neurodegenerative disorders. Folia Neu-ropathol 43, 311-321.
17. Gaikwad S, Larionov S, Wang Y, Dannenberg H, Matozaki T, Monsonego A, Thal DR, Neumann H (2009) Signal regulato- ry protein-beta1: a microglial modulator of phagocytosis in Alzheimer's disease. Am J Pathol 175, 2528-2539.
18. Mrak RE, Griffin WS (2007) Common inflammatory mechanisms in Lewy body disease and Alzheimer disease. J Neu-ropathol Exp Neurol 66, 683-686. (Pubitemid 47344247)
19. Schwab C, McGeer PL (2008) Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J Alzheimers Dis 13, 359-369. (Pubitemid 352039027)
20. Gao HM, Hong JS, Zhang W, Liu B (2002) Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 22, 782-790. (Pubitemid 34141759)
21. Lee M, Schwab C, Yu S,McGeer E,McGeer PL(2009) Astro-cytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiol Aging 30, 1523-1534.
22. Tay AS, Hu LF, Lu M, Wong PT, Bian JS (2010) Hydrogen sulfide protects neurons against hypoxic injury via stimulation of ATP-sensitive potassium channel/protein kinase C/extracellular signal-regulated kinase/heat shock protein 90 pathway. Neuroscience 167, 277-286.
23. Abe K, Kimura H (1996) Amyloid beta toxicity consists of a Ca(2+)-independent early phase and a Ca(2+)-dependent late phase. J Neurochem 67, 2074-2078. (Pubitemid 26349684)
24. Varvel NH, Bhaskar K, Patil AR, Pimplikar SW, Herrup K, Lamb BT (2008) Abeta oligomers induce neuronal cell cycle events in Alzheimer's disease. J Neurosci 28, 10786-10793.
25. Arendt T, Rodel L, Gartner U, Holzer M (1996) Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport 7, 3047-3049. (Pubitemid 26426387)
26. Mohapatra S, Park SJ, Boyapalle S, Pastey MK, Graham BS, Blanck G (2009) Human respiratory syncytial virus reduces the number of cells in S-phase and increases GADD153 expression in HEp-2 cells. Acta Virol 53, 207-211.
27. Kato MA, Finley DJ, Lubitz CC, Zhu B, Moo TA, Loeven MR, Ricci JA, Zarnegar R, Katdare M, Fahey TJ, 3rd Selenium decreases thyroid cancer cell growth by increasing expression of GADD153 and GADD34. Nutr Cancer 62, 66-73.
28. Schwab JM, Beschorner R, Meyermann R, Gozalan F, Schlue-sener HJ (2002) Persistent accumulation ofcyclooxygenase-1- expressing microglial cells and macrophages and transient up-regulation by endothelium in human brain injury. J Neurosurg 96, 892-899. (Pubitemid 34415404)
29. Hoozemans JJ, Rozemuller AJ, Janssen I, De Groot CJ, Veer-huis R, Eikelenboom P (2001) Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain. Acta Neuropathol 101, 2-8. (Pubitemid 32124493)
30. PlataniasLC(2003)Map kinase signaling pathways and hema-tologic malignancies. Blood 101, 4667-4679. (Pubitemid 36857719)
31. Cohen TS, Gray Lawrence G, Khasgiwala A, Margulies SS MAPK activation modulates permeability of isolated rat alveolar epithelial cell monolayers following cyclic stretch. PLoS ONE 5, e10385.
32. Gines S, Paoletti P, Alberch J (2010) Impaired TrkB-mediated ERK1/2 activation in Huntington's disease knock-in striatal cells involves reduced p52/p46 Shc expression. J Biol Chem 285, 21537-21548.
33. Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW, Bradshaw PC (2010) Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. J Alzheimers Dis 20(Suppl 2), S535-S550.
34. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH (2006) Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15, 1437-1449.
35. Reddy PH (2009) Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's disease. CNS Spectr 14, 8-13; discussion 16-18.
36. Mentlein R, Ludwig R, Martensen I (1998) Proteolytic degradation of Alzheimer's disease amyloid beta-peptide by a met-alloproteinase from microglia cells. J Neurochem 70, 721-726. (Pubitemid 28079362)
37. Shaffer LM, Dority MD, Gupta-Bansal R, Frederickson RC, Younkin SG, Brunden KR (1995) Amyloid beta protein (A beta) removal by neuroglial cells in culture. Neurobiol Aging 16, 737-745.